Bora CDMO Bora CDMO

X

CAS 1187595-85-2 manufacturers and suppliers on PharmaCompass

PharmaCompass
[1-(Ethylsulfonyl)Azetidin-3-Ylidene]Acetonitrile
Also known as: 1187595-85-2, 2-[1-(ethanesulfonyl)azetidin-3-ylidene]acetonitrile, [1-(ethylsulfonyl)azetidin-3-ylidene]acetonitrile, 2-[1-(ethylsulfonyl)-3-azetidinylidene]acetonitrile, 2-(1-ethylsulfonylazetidin-3-ylidene)acetonitrile, Schembl871344
Molecular Formula
C7H10N2O2S
Molecular Weight
186.23  g/mol
InChI Key
HQUIOHSYUKWGOM-UHFFFAOYSA-N

1 2D Structure

[1-(Ethylsulfonyl)Azetidin-3-Ylidene]Acetonitrile

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
2-(1-ethylsulfonylazetidin-3-ylidene)acetonitrile
2.1.2 InChI
InChI=1S/C7H10N2O2S/c1-2-12(10,11)9-5-7(6-9)3-4-8/h3H,2,5-6H2,1H3
2.1.3 InChI Key
HQUIOHSYUKWGOM-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CCS(=O)(=O)N1CC(=CC#N)C1
2.2 Synonyms
2.2.1 Depositor-Supplied Synonyms

1. 1187595-85-2

2. 2-[1-(ethanesulfonyl)azetidin-3-ylidene]acetonitrile

3. [1-(ethylsulfonyl)azetidin-3-ylidene]acetonitrile

4. 2-[1-(ethylsulfonyl)-3-azetidinylidene]acetonitrile

5. 2-(1-ethylsulfonylazetidin-3-ylidene)acetonitrile

6. Schembl871344

7. Amy4434

8. Dtxsid801221980

9. Bcp13973

10. Cs-m2446

11. Mfcd22987586

12. Akos025146561

13. Zinc114741608

14. Ds-8954

15. Sb52163

16. Ac-30033

17. Da-31808

18. Ft-0744137

19. P13428

20. (1-ethanesulfonyl-azetidin-3-ylidene)-acetonitrile

21. A892929

2.3 Create Date
2012-08-19
3 Chemical and Physical Properties
Molecular Weight 186.23 g/mol
Molecular Formula C7H10N2O2S
XLogP3-0.9
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count4
Rotatable Bond Count2
Exact Mass186.04629874 g/mol
Monoisotopic Mass186.04629874 g/mol
Topological Polar Surface Area69.6 Ų
Heavy Atom Count12
Formal Charge0
Complexity333
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Flag China
Digital Content Digital Content
URL Supplier Web Content
1224944-77-7
Baricitinib
Established in 1999, Hankang Pharmaceutical Group stands as a prominent CRO-CDMO integrated service enter...
Established in 1999, Hankang Pharmaceutical Group stands as a prominent CRO-CDMO integrated service enterprise in China. Focused on generic drugs while venturing into innovative ones, the group is dedicated to offering comprehensive solutions to the industry. Presently, Hankang has crafted over 200 varieties for 600+ domestic and international companies, serving 10+ innovative drugs. It has successfully developed more than 10 initial generic drugs, with over 20 varieties endorsed by the top three domestic companies and 30 exceeding a 100 million output value.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY